"Today, the U.S. Food and Drug Administration approved Kanuma (sebelipase alfa) as the first treatment for patients with a rare disease known as lysosomal acid lipase (LAL) deficiency.
Patients with LAL deficiency (also known as Wolman disea"...
No information provided. Please refer to the WARNINGS AND PRECAUTIONS section.
Last reviewed on RxList: 10/19/2015
This monograph has been modified to include the generic and brand name in many instances.
Additional Ic-Green Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.